Arovella Therapeutics Ltd (ALA.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALA.AX | ||||
| Company | Arovella Therapeutics Ltd | ||||
| Price Information | |||||
| Exchange | ASX | ||||
| Open | 0.086 | ||||
| High | 0.086 | ||||
| Low | 0.083 | ||||
| Latest | 0.083 | ||||
| Change | -0.003 | ||||
| % Change | -3.49% | ||||
| Volume | 243,430 | ||||
| 20-Day Average Volume | 1,079,126 | ||||
| Previous Close | 0.086 | ||||
| Industry | N/A | ||||
| Has Options | No | ||||
| Technicals | |||||
| 20-Day Moving Average | 0.091 | ||||
| 20-Day Raw Stochastic | 0.00% | ||||
| 20-Day Relative Strength | 44.10 | ||||
| Weighted Alpha | -28.95 | ||||
| Today's Opinion | 48% Sell | ||||
| Previous Opinion | 40% Sell | ||||
| Last Month's Opinion | 24% Sell | ||||
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.74% since 02/19/26 | ||||
| Low | 0.083 on 02/26/26 | ||||
| High | 0.092 on 02/20/26 | ||||
| 1-Month | |||||
| %Chg | -6.74% since 01/23/26 | ||||
| Low | 0.081 on 01/28/26 | ||||
| High | 0.100 on 02/10/26 | ||||
| 3-Month | |||||
| %Chg | +1.22% since 11/26/25 | ||||
| Low | 0.073 on 12/30/25 | ||||
| High | 0.100 on 02/10/26 | ||||
| 6-Month | |||||
| %Chg | -5.68% since 08/26/25 | ||||
| Low | 0.073 on 12/30/25 | ||||
| High | 0.125 on 10/02/25 | ||||
| Key Statistics | |||||
| Market Capitalization, $K | 103,818 | ||||
| Shares Outstanding, K | 1,201,184 | ||||
| Annual Sales | 136,000 | ||||
| Annual Net Income | -7,509,166 | ||||
| Last Quarter Sales | N/A | ||||
| Last Quarter Net Income | N/A | ||||
| 60-Month Beta | N/A | ||||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | ||||
| Latest Earnings Date | N/A | ||||
| Most Recent Dividend | N/A | ||||
| Next Ex-Dividends Date | N/A | ||||
| Ratios | |||||
| Price/Earnings ttm | N/A | ||||